89BIO (ETNB)
(Delayed Data from NSDQ)
$9.34 USD
+0.18 (1.97%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $9.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ETNB 9.34 +0.18(1.97%)
Will ETNB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ETNB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ETNB
Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips
Vaxcyte Stock Plummets 56% in a Month: Here's the Reason
ETNB: What are Zacks experts saying now?
Zacks Private Portfolio Services
VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study
VRTX Secures Nod for Expanded Use of CF Drug Kaftrio in Europe
FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug
Other News for ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ETNB Stock News
Altimmune: Potential Tough Road Ahead Amid Fierce Competition (Rating Downgrade)
89bio Inc (ETNB) Announces Inducement Grants for New Employees | ETNB stock news
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ETNB Stock News
Empery Asset Management, LP Reduces Stake in Volcon Inc